Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States
M Alvarez JH Tran N Chow 2004 Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States Antimicrob Agents Chemother 48 533 537
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
PA Bradford C Urban N Mariano 1997 Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein Antimicrob Agents Chemother 41 563 569
A functional classification scheme for beta-lactamases and its correlation with molecular structure
K Bush GA Jacoby AA Medeiros 1995 A functional classification scheme for beta-lactamases and its correlation with molecular structure Antimicrob Agents Chemother 39 1211 1233
Survey of prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae
C Chanal D Sirot JP Romaszko 1996 Survey of prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae J Antimicrobial Chemotherapy 38 127 132
Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli
J Cheng Y Ye YY Wang 2008 Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli Acta Pharmacol Sin 29 217 225
Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital
M Gazouli ME Kaufmann E Tzelepi 1997 Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital J Clin Microbiol 35 508 510
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class a beta-lactamase isolated from Escherichia coli
Y Ishii A Ohno H Taguchi 1995 Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli Antimicrob Agents Chemother 39 2269 2275
Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK
PJ Jenks YM Hu F Danel 1995 Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK J Antimicrob Chemother 35 235 236
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens:the AmpC enzymes
RN Jones 1998 Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens:the AmpC enzymes Diagn Microbiol Infect Dis 31 461 466
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae
GA Papanicolaou AA Medeiros GA Jacoby 1990 Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae Antimicrob Agents Chemother 34 2200 2209
Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein
PD Stapleton KP Shannon GL French 1999 Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein Antimicrob Agents Chemother 43 1206 1210
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan
JJ Yan SM Wu SH Tsai 2000 Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan Antimicrob Agents Chemother 44 1438 1442